FEB 13, 2020 5:04 AM PST

Protein that suppresses immune system linked to lupus

WRITTEN BY: Tara Fernandez

 

A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and the development of systemic lupus erythematosus, or SLE. This protein, human leukocyte antigen G (HLA-G), is expressed on fetal derived placental cells and is thought to play a role in immune tolerance during pregnancy.

HLA-G has been the subject of intense study in the last two decades. In particular, scientists have been interested in how HLA-G-mediated pathways affect rejection after organ transplantation, or how tumors suppress hijack these to evade immune detection. 

Now, the research team led by Francesco Puppo at the University of Genoa has identified that patients with SLE have significantly elevated levels of HLA-G. The protein was found on the membrane of peripheral blood mononuclear cells, a subset of white blood cells that includes T cells and monocytes. The significant difference in HLA-G levels between lupus patients and healthy controls points to the protein’s possible involvement in the onset or progression of this autoimmune disease.

SLE affects nearly every organ system from the skin, joints and central nervous system to the brain and kidneys. The disease is more prevalent in women than men and is thought to be a result of complex genetic, environmental and hormonal factors. Lupus is characterized by an exaggerated immune response to the body’s own cells and tissues, causing this widespread organ damage.

 

 

Based on their findings, the authors hypothesize that the increased production of HLA-G on the surface of immune cells could reflect an attempt to control the imbalanced immune responses occurring during the systemic autoimmune diseases.

Further clinical studies are due to establish whether HLA-G could be leveraged for diagnostic or therapeutic purposes.

 

Sources: Scleroderma News, Human Immunology.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 04, 2019
Immunology
AUG 04, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
SEP 14, 2019
Genetics & Genomics
SEP 14, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
NOV 11, 2019
Neuroscience
NOV 11, 2019
Suicidal Mitochondria Responsible for ALS
Scientists at Northwestern University have dicovered a new mechanism in the brain that may be responsable for the early stages of neurodegeneration seen in...
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug To Treat Ulcerative Colitis
Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmu...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
Potential Cure for Coronavirus Found in Thailand
Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Alt...
Loading Comments...